Jump Capital announced the sale of Champion Healthcare Technologies to The Riverside Co., a Cleveland-based private equity firm. Champion will be combined with HemaTerra Technologies, a recent Riverside investment that provides software solutions to hospital-based and independent blood and plasma collection centers. Terms of the transaction were not disclosed.
Based in Lake Zurich, Champion is a software-as-a-service provider for hospitals to track and manage tissue and implantable devices throughout their chain of custody to enable regulatory compliance, improve patient safety, and increase cost savings by optimizing device utilization.
Since Chicago-based Jump Capital first invested in Champion in 2013, the team supported the company financially and operationally, with deep engagements from its operating partner team that helped the company grow its revenue nearly 6 times since its initial investment.
“Champion’s ability to attract, retain, and grow its loyal customer footprint has been a remarkable story and we are proud to have been part of the company’s journey,” Jump Capital Managing Partner Mike McMahon said in a statement. “We are very happy for the team to find a great home and future partner in Riverside.”
Champion’s proprietary UDITracker and WarrantyTracker products serve some of the largest health systems in the U.S.
“Champion is a prime example of Jump’s commitment to providing not only financial resources for its portfolio companies, but also executive advisory and operating engagements to drive growth-oriented and disciplined decision making,” Jump Operating Partner and Champion’s Chief Financial Officer Pete Carroll said in a statement.
Jump Capital is a series A/B venture & growth capital firm that provides capital and strategic resources for companies within the B2B SaaS, media, IT/Data infrastructure, and Fintech sectors. Since its founding in 2012, Jump has made more than 50 technology-based investments.
